NOVÁ DOPORUČENÍ / NEW RECOMMENDATIONS Komentovaný souhrn doporučení Evropské společnosti intenzivní medicíny (ESICM) 2023 pro management ARDS | 195 / Anest intenziv Med. 2023;34(4):184-195 / ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA www.aimjournal.cz Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2019 Mar 5;321(9):846-857. doi: 10.1001/ jama.2019.0555. PMID: 30776290; PMCID: PMC6439595. 36. Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators; Cavalcanti AB, Suzumura ÉA, Laranjeira LN, Paisani DM, Damiani LP, Guimarães HP, et al. Effect of Lung Recruitment and Titrated Positive End‑Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1335-1345. doi: 10.1001/ jama.2017.14171. PMID: 28973363; PMCID: PMC5710484. 37. Cutuli SL, Grieco DL, Michi T, Cesarano M, Rosà T, Pintaudi G, et al. Personalized Respiratory Support in ARDS: A Physiology‑to‑Bedside Review. J Clin Med. 2023 Jun 21;12(13):4176. doi: 10.3390/jcm12134176. PMID: 37445211; PMCID: PMC10342961. 38. Sarge T, Baedorf‑Kassis E, Banner‑Goodspeed V, Novack V, Loring SH, Gong MN, et al; EPVent-2 Study Group. Effect of Esophageal Pressure‑guided Positive End‑Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk‑based and Mechanistic Reanalysis of the EPVent-2 Trial. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1153-1163. doi: 10.1164/rccm.202009-3539OC. PMID: 34464237; PMCID: PMC8759303. 39. Marini JJ, Gattinoni L. Time Course of Evolving Ventilator‑Induced Lung Injury: The „Shrinking Baby Lung“. Crit Care Med. 2020 Aug;48(8):1203-1209. doi: 10.1097/ CCM.0000000000004416. PMID: 32697492; PMCID: PMC7217130. 40. Constantin JM, Jabaudon M, Lefrant JY, Jaber S, Quenot JP, Langeron O, et al; AZUREA Network. Personalised mechanical ventilation tailored to lung morphology versus low positive end‑expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single‑blind, randomised controlled trial. Lancet Respir Med. 2019 Oct;7(10):870-880. doi: 10.1016/S2213-2600(19)30138-9. Epub 2019 Aug 6. PMID: 31399381. 41. Chen L, Del Sorbo L, Grieco DL, Junhasavasdikul D, Rittayamai N, Soliman I, et al. Potential for Lung Recruitment Estimated by the Recruitment‑to‑Inflation Ratio in Acute Respiratory Distress Syndrome. A Clinical Trial. Am J Respir Crit Care Med. 2020 Jan 15;201(2):178187. doi: 10.1164/rccm.201902-0334OC. PMID: 31577153. 42. Mlček M, Otáhal M, Borges JB, Alcala GC, Hladík D, Kuriščák E, et al. Targeted lateral positioning decreases lung collapse and overdistension in COVID-19-associated ARDS. BMC Pulm Med. 2021 Apr 24;21(1):133. doi: 10.1186/s12890-021-01501-x. PMID: 33894747; PMCID: PMC8065309. 43. Fan E, Wilcox ME, Brower RG, Stewart TE, Mehta S, Lapinsky SE, et al. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med. 2008 Dec 1;178(11):1156-63. doi: 10.1164/rccm.200802-335OC. Epub 2008 Sep 5. PMID: 18776154. 44. Hodgson CL, Tuxen DV, Davies AR, Bailey MJ, Higgins AM, Holland AE, et al. A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome. Crit Care. 2011;15(3):R133. doi: 10.1186/cc10249. Epub 2011 Jun 2. PMID: 21635753; PMCID: PMC3219001. 45. Hodgson CL, Cooper DJ, Arabi Y, King V, Bersten A, Bihari S, et al. Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 Dec 1;200(11):1363-1372. doi: 10.1164/rccm.201901-0109OC. PMID: 31356105. 46. Kung SC, Hung YL, Chen WL, Wang CM, Chang HC, Liu WL. Effects of Stepwise Lung Recruitment Maneuvers in Patients with Early Acute Respiratory Distress Syndrome: A Prospective, Randomized, Controlled Trial. J Clin Med. 2019 Feb 10;8(2):231. doi: 10.3390/ jcm8020231. PMID: 30744214; PMCID: PMC6406466. 47. Kung SC, Hung YL, Chen WL, Wang CM, Chang HC, Liu WL. Effects of Stepwise Lung Recruitment Maneuvers in Patients with Early Acute Respiratory Distress Syndrome: A Prospective, Randomized, Controlled Trial. J Clin Med. 2019 Feb 10;8(2):231. doi: 10.3390/ jcm8020231. PMID: 30744214; PMCID: PMC6406466. 48. Kacmarek RM, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J, et al; Open Lung Approach Network. Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial. Crit Care Med. 2016 Jan;44(1):32-42. doi: 10.1097/ CCM.0000000000001383. PMID: 26672923. 49. Xi XM, Jiang L, Zhu B; RM group. Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial. Chin Med J (Engl). 2010 Nov;123(21):31005. PMID: 21162963. 50. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20. PMID: 23688302. 51. Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, et al; Prone‑Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001 Aug 23;345(8):568-73. doi: 10.1056/NEJMoa010043. PMID: 11529210. 52. Guerin C, Gaillard S, Lemasson S, Ayzac L, Girard R, Beuret P, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004 Nov 17;292(19):2379-87. doi: 10.1001/jama.292. 19. 2379. PMID: 15547166. 53. Mancebo J, Fernández R, Blanch L, Rialp G, Gordo F, Ferrer M, et al. A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006 Jun 1;173(11):1233-9. doi: 10.1164/rccm.200503-353OC. Epub 2006 Mar 23. PMID: 16556697. 54. Taccone P, Pesenti A, Latini R, Polli F, Vagginelli F, Mietto C, et al; Prone‑Supine II Study Group. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2009 Nov 11;302(18):1977-84. doi: 10.1001/ jama.2009.1614. PMID: 19903918. 55. Weatherald J, Parhar KKS, Al Duhailib Z, Chu DK, Granholm A, Solverson K, et al. Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta‑analysis of randomized trials. BMJ. 2022 Dec 7;379:e071966. doi: 10.1136/bmj-2022-071966. PMID: 36740866; PMCID: PMC9727649. 56. Ehrmann S, Li J, Ibarra‑Estrada M, Perez Y, Pavlov I, McNicholas B, et al; Awake Prone Positioning Meta‑Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open‑label meta‑trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20. PMID: 34425070; PMCID: PMC8378833. 57. Rosén J, von Oelreich E, Fors D, Jonsson Fagerlund M, Taxbro K, Skorup P, et al; PROFLO Study Group. Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care. 2021 Jun 14;25(1):209. doi: 10.1186/s13054-021-03602-9. PMID: 34127046; PMCID: PMC8200797. 58. Alhazzani W, Parhar KKS, Weatherald J, Al Duhailib Z, Alshahrani M, Al‑Fares A, et al; COVI ‑PRONE Trial Investigators and the Saudi Critical Care Trials Group. Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2022 Jun 7;327(21):2104-2113. doi: 10.1001/jama.2022.7993. PMID: 35569448; PMCID: PMC9108999. 59. Papazian L, Forel JM, Gacouin A, Penot‑Ragon C, Perrin G, Loundou A, et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372. PMID: 20843245. 60. Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta ‑Analysis. Crit Care Med. 2016 Nov;44(11):2070-2078. doi: 10.1097/CCM.0000000000001839. PMID: 27513545. 61. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019 May 23;380(21):1997-2008. doi: 10.1056/NEJMoa1901686. Epub 2019 May 19. PMID: 31112383; PMCID: PMC6741345. 62. Tsolaki V, Zakynthinos GE, Papadonta ME, Bardaka F, Fotakopoulos G, Pantazopoulos I, et al. Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients. J Pers Med. 2022 Sep 19;12(9):1538. doi: 10.3390/jpm12091538. PMID: 36143323; PMCID: PMC9504585. 63. Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, et al. Association of hospital‑level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901. doi: 10.1164/rccm.201409-1634OC. PMID: 25695688; PMCID: PMC4435456. 64. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009 Oct 17;374(9698):1351-63. doi: 10.1016/ S0140-6736(09)61069-2. Epub 2009 Sep 15. Erratum in: Lancet. 2009 Oct 17;374(9698):1330. PMID: 19762075. 65. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al; EOLIA Trial Group, REVA, and ECMONet. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018 May 24;378(21):1965-1975. doi: 10.1056/ NEJMoa1800385. PMID: 29791822. 66. Shaefi S, Brenner SK, Gupta S, O’Gara BP, Krajewski ML, Charytan DM, et al; STOP‑COVID Investigators. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med. 2021 Feb;47(2):208-221. doi: 10.1007/s00134-02006331-9. Epub 2021 Feb 2. PMID: 33528595; PMCID: PMC7851810. 67. Whebell S, Zhang J, Lewis R, Berry M, Ledot S, Retter A, et al. Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi‑centre‑matched cohort study. Intensive Care Med. 2022 Apr;48(4):467-478. doi: 10.1007/s00134-022-06645-w. Epub 2022 Mar 3. Erratum in: Intensive Care Med. 2022 Mar 18: PMID: 35238946; PMCID: PMC8892395. 68. Bein T, Weber‑Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‚conventional’ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent‑study. Intensive Care Med. 2013 May;39(5):847-56. doi: 10.1007/s00134-012-2787-6. Epub 2013 Jan 10. PMID: 23306584; PMCID: PMC3625408. 69. McNamee JJ, Gillies MA, Barrett NA, Perkins GD, Tunnicliffe W, Young D, et al; REST Investigators. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA. 2021 Sep 21;326(11):1013-1023. doi: 10.1001/jama.2021.13374. Erratum in: JAMA. 2022 Jan 4;327(1):86. PMID: 34463700; PMCID: PMC8408762.
RkJQdWJsaXNoZXIy NDA4Mjc=